News

Online cancer journal features the SentiMag - 27 January 2010. In a webcast published today in the cancer journal eCancer, Endomagnetics' founder Quentin Pankhurst demonstrates the new SentiMag in action, and breast cancer surgeon Michael Douek describes his new clinical trial on the use of magnetic tracers for sentinel node detection.

Surgeons enthusiastic over new SentiMag - press release 5 January 2010. Following a successful product launch at the San Antonio Breast Cancer Symposium, Endomagnetics' founder Quentin Pankhurst reports that the response from surgeons was “overwhelmingly positive” and “validated our goal to offer a surgeon-friendly and cost-effective alternative to radioactive materials for the treatment of breast cancer”.

Endomagnetics unveils new SentiMag - press release 8 December 2009. Endomagnetics today unveiled its new SentiMag system for sentinel lymph node detection. The new SentiMag features a fully integrated and compact bench-top control unit, and a newly designed light and flexible hand-held probe. The system uses a proprietary magnetic sensor that is a major departure from previous ones that required liquid nitrogen cooling.

Endomagnetics to exhibit at San Antonio Breast Cancer Symposium - 9 October 2009. Endomagnetics will exhibit at the 32nd San Antonio Breast Cancer Symposium at the Henry B. Gonzalez Convention Center in San Antonio, Texas, on 10-12 December 2009. The symposium is the largest of its kind in the world, and last year attracted 9,000 registered attendees. Endomagnetics will be showcasing their latest technology at Stand 142.

Endomagnetics closes funding round - press release 1 October 2009. Endomagnetics today announced the completion of a funding round to support commercialisation of the SentiMag. The round was led by UCL Business PLC, with contributions from the Combined London Colleges University Challenge Seed Fund, the Bloomsbury Bioseed Fund, and the company founders and their friends and families.

Isotope crisis threatens medical care - 14 August 2009. In an article published today in ScienceNews, it was revealed that a new shortage of radioactive tracer materials is threatening the ability of doctors to measure the spread of breast cancer. The reason: temporary shutdowns of Canadian and Dutch reactors that together normally provide some 70 percent of the world’s supplies of the isotope molybdenum-99 and at least 80 percent of North American supplies.

Endomagnetics wins 2007 Innova Award - 28 January 2008. It was announced today that Endomagnetics has been awarded the 2007 Innova Award for Best Technology. The company received the award after a ballot of the readers of the American magnetics industry trade bulletin, Magnetics Magazine, in recognition of having developed, in 2007, 'the technology that has the most promise of impacting and improving the magnetics industry'.

First clinical trials of magnetic approach to node detection - press release 5 March 2007. On a visit to Houston, breast cancer surgeon Mr Michael Douek describes initial results from clinical trials of the new SentiMag approach to sentinel node detection. The initial trials, which commenced at University College London Hospital in December 2006, are to involve a cohort of 10 subjects.

Endomagnetics receives plaudits from Prince Andrew - press release 31 October 2006. Prince Andrew, the Duke of York and the UK Government's Special Respresentative for International Trade and Investment, has prasied Endomagnetics as an exemplar of nanotechnology innovation. Speaking to an audience of 1000 at the Nano-TX trade fair in Dallas this month, the Duke spoke of Endomagnetics as '.. an exciting example of the early stages of this kind of progress.' A video clip of the Duke's speech is available here.